India’s MedTech Future Hinges On Regulatory Reform And Global Alignment: MTaI’s Pavan Choudary
Medtech Insight Sat Down With Trade Group Head Pavan Choudary To Discuss FTAs, US Tariffs, Regulatory Harmonization And Ban On Import Of Refurbished Products
Offering a clear-eyed view of both opportunities and challenges, Choudary lays out a pragmatic road map for India’s medtech industry to scale globally while remaining responsive to domestic healthcare needs.
